Clinical Trial: Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye(R)) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks

U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07368595) titled 'Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye(R)) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks' on Jan. 20.

Brief Summary: This goal of this clinical trial is to compare the effects of two approved cyclosporine eye drops that have different concentrations and vehicles on the number of mucus producing conjunctival goblet cells in patients with dry eye disease to learn which one causes the greatest increase.

The main questions it aims to answer are:

Does one drug cause a greater increase in goblet cells? How many weeks does it take to...